BRAIN Biotech AG stays on solid growth path with H1 results and accelerates One-BioProducts strategy

25 May 2023, Zwingenberg (Germany) - BRAIN Biotech AG, a leading provider of integrated solutions for the biologization of industry, today published its half year results, 6M 2022/2023. The company stays on track to deliver on its full year financial targets and has accelerated its One-BioProducts strategy by acquiring full ownership of its core production asset Biocatalysts Ltd, Wales.